<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00470808</url>
  </required_header>
  <id_info>
    <org_study_id>0051-07-EMC</org_study_id>
    <nct_id>NCT00470808</nct_id>
  </id_info>
  <brief_title>The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients</brief_title>
  <acronym>POMX</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes is a highly atherogenic disease. Pomegranate juice has impressive antioxidant
      properties. It has been proven to decrease oxidant stress and to cause the regression of
      atherosclerotic plaques in hypercholestrolemic and diabetic patients.Furthermore it has been
      proven to potentiate the biologic activity of the enzyme paraoxonase 1 which is very
      important in preventing atherosclerosis. The study will try to prove that a polyphenolic
      extract from pomegranate (POMx) has the same desired effects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <completion_date type="Anticipated">August 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Atherosclerosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>POMx</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males

          -  HBA1C&gt;7%

          -  Drug therapy given for DM

        Exclusion Criteria:

          -  Age&lt;18

          -  Inclusion in another study
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wasseem Rock, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ha'Emek Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wasseem Rock, MD</last_name>
    <phone>0547866896</phone>
    <email>wasseem_rock@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ha'Emek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wasseem Rock, MD</last_name>
      <phone>0547-866806</phone>
    </contact>
    <investigator>
      <last_name>Wasseem Rock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2007</study_first_submitted>
  <study_first_submitted_qc>May 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2007</study_first_posted>
  <last_update_submitted>May 7, 2007</last_update_submitted>
  <last_update_submitted_qc>May 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2007</last_update_posted>
  <keyword>Minors</keyword>
  <keyword>Enrollment in another study</keyword>
  <keyword>Males</keyword>
  <keyword>HBA1C greater than 7</keyword>
  <keyword>Drug therapy for DM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

